Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for IMCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 699.62M
March 31, 2026 678.42M
December 31, 2025 686.24M
September 30, 2025 705.94M
June 30, 2025 693.91M
March 31, 2025 649.53M
December 31, 2024 648.79M
September 30, 2024 706.81M
June 30, 2024 664.23M
March 31, 2024 634.45M
December 31, 2023 228.16M
September 30, 2023 210.64M
June 30, 2023 207.34M
March 31, 2023 193.43M
Date Value
December 31, 2022 188.57M
September 30, 2022 167.28M
June 30, 2022 158.99M
March 31, 2022 156.34M
December 31, 2021 176.38M
September 30, 2021 173.74M
June 30, 2021 180.80M
March 31, 2021 186.74M
December 31, 2020 193.90M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 226.37M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Silence Therapeutics Plc 67.94M
Biodexa Pharmaceuticals Plc --
NuCana Plc 7.330M
Mereo BioPharma Group Plc 6.062M
Compass Pathways Plc 420.03M

Total Liabilities (Quarterly) Related Metrics